ArticleJournal of experimental pharmacology2025
Protective Effects of Tamarillo (
Article in Journal of experimental pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the protective effects of Tamarillo ( Methods: A post-test-only control group experimental study was conducted on Balb/c mice. Thirty-five male mice 12 weeks old were randomly divided into 5 groups: two control groups (K-, K+) and three treatment groups (P1, P2, P3). The K- received distilled water, and the K+ received 75 mg/kg lead acetate. The P1, P2, and P3 received 100, 200, and 400 mg/kg of Tamarillo crude extracts (TCE), respectively for 35 days, and on the fourth day, were given lead acetate 75 mg/kg one hour after the TCE administration by gavage tube. The effect of TCE against lead-induced oxidative stress in mice was determined by the expression of mouse testicular apoptosis using terminal deoxynucleotidyl Transferase-mediated dUTP nick end labeling (TUNEL) assay, the expression of Caspase-3, and SOD. Results: TCE at the dose of 400 mg/kg showed comparable apoptosis and SOD expression to the negative control group (K-). Notably, the level of Caspase-3 among treatment groups showed lower expression than the K- group despite the injection of lead acetate. Conclusion: This study demonstrated that TCE exhibits antioxidant activity and protects the reproductive system by inhibiting lead acetate to induce oxidative damage and testicular damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.